GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » J.Molner AS (OTSE:MOLNR) » Definitions » Net Income From Continuing Operations

J.Molner AS (OTSE:MOLNR) Net Income From Continuing Operations : €-1.09 Mil (TTM As of Dec. 2023)


View and export this data going back to 2022. Start your Free Trial

What is J.Molner AS Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. J.Molner AS's net income from continuing operations for the six months ended in Dec. 2023 was €-0.64 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Dec. 2023 was €-1.09 Mil.


J.Molner AS Net Income From Continuing Operations Historical Data

The historical data trend for J.Molner AS's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

J.Molner AS Net Income From Continuing Operations Chart

J.Molner AS Annual Data
Trend Dec21 Dec22 Dec23
Net Income From Continuing Operations
-0.33 -0.62 -1.09

J.Molner AS Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23
Net Income From Continuing Operations - -0.25 -0.37 -0.45 -0.64

J.Molner AS Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-1.09 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


J.Molner AS (OTSE:MOLNR) Business Description

Industry
Traded in Other Exchanges
N/A
Address
Akadeemia tee 21/5, Harju maakond, Tallinn, EST, 12618
J.Molner AS is an Estonia-based company. The company is engaged in research and development in the field of biotechnology. The activities of the Company are divided into two fields: 1) Chemistry analytical and development services for third parties; 2) Development of the Company's own line of generic pharmaceuticals.

J.Molner AS (OTSE:MOLNR) Headlines

No Headlines